Acetic Acid Ear Drops Shortage: What Providers and Prescribers Need to Know in 2026

Clinicians prescribing acetic acid otic solution (2%) for otitis externa are increasingly encountering a consistent frustration: patients return to say their prescription could not be filled. While acetic acid otic does not appear on the FDA's current official drug shortage list, real-world availability at the pharmacy level is inconsistent and worsening in some regions. This guide provides a clinically grounded overview of the situation and actionable strategies for your practice.

Current Availability Landscape

The discontinuation of the VoSol brand — confirmed by the FDA in May 2025 as not safety-related — has narrowed the commercial footprint of acetic acid otic. Generic versions remain FDA-approved, but only a limited number of manufacturers produce the 2% otic solution. This, combined with the medication's low per-unit margin (retail pricing roughly $24–$40), means pharmacies prioritize it poorly in their ordering systems.

The practical result: many chain pharmacies do not routinely stock acetic acid otic, and when they do, summer demand spikes for swimmer's ear treatment can deplete supply quickly. Independent pharmacies and compounding pharmacies represent the most reliable fallback options for patients who specifically need this formulation.

Mechanism and Therapeutic Role

Acetic acid otic (2%) exerts its antimicrobial effect by lowering intraluminal pH to approximately 3, creating an environment that is bacteriostatic and fungistatic. The formulation includes propylene glycol as a hydrophilic vehicle and benzethonium chloride as a surfactant to optimize tissue contact. Its primary indication remains uncomplicated acute otitis externa (AOE) in patients aged 3 years and older with an intact tympanic membrane.

Acetic acid's antiseptic mechanism means it is not a true antibiotic and does not confer antibiotic resistance. This can be clinically advantageous in low-to-moderate severity AOE cases where the broader antimicrobial spectrum of fluoroquinolones is not necessary.

Evidence-Based Alternatives When Acetic Acid Is Unavailable

When acetic acid otic cannot be dispensed, the following alternatives offer strong evidence for treating AOE:

Ofloxacin Otic 0.3%

Ofloxacin otic is widely considered a first-line alternative for bacterial AOE. Nationwide Children's Hospital's otitis externa guidelines recommend ofloxacin 0.3% for most patients. In clinical trials of otitis externa, ofloxacin achieved overall cure rates of 97% in pediatric patients and 82% in adult patients. Key advantages include safety with tympanic membrane perforation, broad coverage against Pseudomonas aeruginosa and Staphylococcus aureus, and wide pharmacy availability at low cost (generic ~$10–$25).

Ciprofloxacin/Dexamethasone (Ciprodex)

Ciprodex (ciprofloxacin 0.3% / dexamethasone 0.1%) is appropriate for moderate-to-severe AOE with significant edema and inflammation. Clinical trials showed clinical cure rates of 87–94% for AOE. The corticosteroid component accelerates resolution of canal edema, which is clinically meaningful in severe cases. It is also FDA-approved for acute otitis media with tympanostomy tubes (AOMT). The main drawback is cost — without insurance, prices can exceed $150. Generic ciprofloxacin/dexamethasone is increasingly available.

Hydrocortisone/Acetic Acid (Acetasol HC)

For providers specifically interested in keeping an acetic acid-based mechanism, the combination product hydrocortisone/acetic acid (Acetasol HC) may be available at pharmacies where plain acetic acid otic is not. It adds hydrocortisone 1% to manage inflammation. This product should not be used in patients with a perforated tympanic membrane or with viral infections (herpes simplex, varicella).

Practical Workflow Recommendations

At time of prescribing: Consider e-prescribing with a DAW (dispense as written) note if you want the generic. If you are flexible on the agent, noting "or ofloxacin otic 0.3% if unavailable" in your prescription notes can save a call-back.

Standing orders: Consider developing a standing protocol for your MA/front desk staff to proactively check pharmacy stock when prescribing acetic acid otic in summer months.

Patient education: Counsel patients at the visit that acetic acid otic may be hard to find and give them an alternate agent as a backup prescription or verbal authorization to have the pharmacist substitute.

Direct patients to medfinder: medfinder.com/providers offers resources for referring patients to a service that calls pharmacies on their behalf to find which ones have the medication in stock.

Contraindications to Keep in Mind

Acetic acid otic: contraindicated with perforated tympanic membrane, hypersensitivity to any component, age under 3 years.

Cortisporin Otic: avoid in patients with tympanic membrane perforation due to neomycin ototoxicity risk.

Ciprodex/Ofloxacin: use with caution in patients with quinolone hypersensitivity.

How medfinder Supports Your Patients

medfinder is a paid service that calls pharmacies near a patient to identify which ones have a specific medication in stock, then texts results to the patient. For practices with high volumes of swimmer's ear cases in summer — or anytime a patient is dealing with a hard-to-find generic — providing patients with the medfinder provider page can reduce callbacks and support a better care experience.